Clinical Trial – Immune Response to Shingles Vaccination – Shingles

2 Answers

These messages are for mutual support and information sharing only. Always consult your doctor before trying anything you read here.
The purpose of this study is to learn more about the immune response to varicella zoster virus (VZV). Participants 70 years of age or older will receive the FDA-approved shingles vaccine (Zostavax). Blood samples and optional skin biopsies will be obtained before and after vaccination to study the immune responses to shingles vaccination.
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Immune Response to Shingles Vaccination
Study Start Date : February 2016
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : December 2018
Contact: Study Coordinator Virology Research Clinic 206-520-4340 Identifier: NCT02624375
For enrollment please visit

body aches, inflammation at injection site and general weakness

How long after vaccination? Do you have a fever? Generally weakness and local inflammation are common within a few days after vaccine shots and can generally disappear days later. If you feel very uncomfortable, calling your doctor is recommended.